We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QIPT
11726
PUT
DELISTED
Quipt Home Medical
QIPT
$59K ﹤0.01%
+12,800
New +$59K
QUAD icon
11727
PUT
Quad
QUAD
$513M
$59K ﹤0.01%
21,300
+10,000
+88% +$48.4K
UP icon
11728
PUT
Wheels Up
UP
$182M
$59K ﹤0.01%
151
-11
-7% -$5.88K
PDYN icon
11729
Palladyne AI
PDYN
$326M
$59K ﹤0.01%
3,710
-13,246
-78% -$328K
NAGE
11730
CALL
Niagen Bioscience
NAGE
$239M
$59K ﹤0.01%
35,500
-94,100
-73% -$184K
ENZ
11731
DELISTED
Enzo Biochem, Inc.
ENZ
$59K ﹤0.01%
28,465
+17,963
+171% +$44.4K
ISUN
11732
DELISTED
iSun, Inc. Common Stock
ISUN
$59K ﹤0.01%
+18,157
New +$61.2K
SALM
11733
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$59K ﹤0.01%
+27,714
New +$78.4K
NM
11734
DELISTED
Navios Maritime Holdings Inc.
NM
$59K ﹤0.01%
27,585
-6,246
-18% -$20.4K
HYRE
11735
DELISTED
HyreCar Inc. Common Stock
HYRE
$59K ﹤0.01%
97,363
+65,527
+206% +$84K
WMC
11736
PUT
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$59K ﹤0.01%
4,860
-820
-14% -$11.1K
ADVM
11737
CALL
DELISTED
Adverum Biotechnologies
ADVM
$58K ﹤0.01%
4,810
-1,800
-27% -$18.9K
BNTC icon
11738
Benitec Biopharma
BNTC
$431M
$58K ﹤0.01%
+2,939
New +$68.3K
BON
11739
Bon Natural Life
BON
$8.94M
$58K ﹤0.01%
+86
New +$87.9K
CPSH icon
11740
PUT
CPS Technologies
CPSH
$83.6M
$58K ﹤0.01%
19,200
+1,800
+10% +$6.68K
MXCT icon
11741
CALL
MaxCyte
MXCT
$136M
$58K ﹤0.01%
+12,200
New +$60.1K
RKDA icon
11742
Arcadia Biosciences
RKDA
$1.5M
$58K ﹤0.01%
1,428
+577
+68% +$26.5K
OLOX
11743
CALL
Olenox Industries
OLOX
$3.7M
$58K ﹤0.01%
6
HLGN
11744
PUT
DELISTED
Heliogen, Inc.
HLGN
$58K ﹤0.01%
791
-1,400
-64% -$182K
TKAT
11745
PUT
DELISTED
Takung Art Co., Ltd.
TKAT
$58K ﹤0.01%
34,800
-10,500
-23% -$23.6K
MNTS icon
11746
Momentus
MNTS
$91.2M
$57K ﹤0.01%
2
-40
-95% -$1.46M
OLMA icon
11747
PUT
Olema Pharmaceuticals
OLMA
$930M
$57K ﹤0.01%
13,900
+2,300
+20% +$7.29K
SMMT icon
11748
Summit Therapeutics
SMMT
$10.6B
$57K ﹤0.01%
+56,743
New +$79.5K
TMC icon
11749
PUT
TMC The Metals Company
TMC
$1.77B
$57K ﹤0.01%
55,400
-17,900
-24% -$27.6K
VIOT
11750
Viomi Technology
VIOT
$47.2M
$57K ﹤0.01%
33,341
+8,898
+36% +$14.4K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.